Epidemiology of the disorders of the Pik3ca-related overgrowth spectrum (Pros)

被引:0
作者
Giuseppe Reynolds
Simona Cardaropoli
Diana Carli
Maria Luca
Andrea Gazzin
Paola Coppo
Roberta La Selva
Marilidia Piglionica
Rosanna Bagnulo
Antonella Turchiano
Carlotta Ranieri
Nicoletta Resta
Alessandro Mussa
机构
[1] University of Torino,Department of Public Health and Pediatric Sciences, School of Medicine
[2] University of Torino,Department of Medical Science
[3] Regina Margherita Children’s Hospital,Pediatric Dermatology
[4] Città della Salute e della Scienza di Torino,Medical Genetics Unit
[5] Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) University of Bari “Aldo Moro”,undefined
[6] Analysis Laboratory “F. Ditonno” SRL,undefined
来源
European Journal of Human Genetics | 2023年 / 31卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
PIK3CA pathogenic variants are responsible for a group of overgrowth syndromes, collectively known as PIK3CA-Related Overgrowth Spectrum (PROS). These gain-of-function variants arise postzygotically, and, according to time of onset, kind of embryonal tissue affected and regional body extension, give rise to heterogeneous phenotypes. PROS rarity and heterogeneity hamper the correct estimation of its epidemiology. Our work represents the first attempt to define the prevalence of PROS according to the established diagnostic criteria and molecular analysis and based on solid demographic data. We assessed the prevalence in Piedmont Region (Italy), including in the study all participants diagnosed with PROS born there from 1998 to 2021. The search identified 37 cases of PROS born across the 25-year period, providing a prevalence of 1:22,313 live births. Molecular analysis was positive in 81.0% of participants. Taking into account the cases with a detected variant in PIK3CA (n = 30), prevalence of molecularly positive PROS was 1:27,519.
引用
收藏
页码:1333 / 1336
页数:3
相关论文
共 84 条
[1]  
Keppler-Noreuil KM(2015)PIK3CA-related overgrowth spectrum (PROS): Diagnostic and testing eligibility criteria, differential diagnosis, and evaluation Am J Med Genet Part A 167 287-95
[2]  
Rios JJ(2012)“Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA Nat Genet. 44 928-33
[3]  
Parker VER(2013)Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly Hum Mol Genet. 22 444-51
[4]  
Semple RK(2020)Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants Clin Genet. 97 736-40
[5]  
Lindhurst MJ(2022)Megalencephaly-Capillary Malformation-Polymicrogyria Syndrome (MCAP): A Rare Dynamic Genetic Disorder Cureus 14 e25123-7
[6]  
Sapp JC(2021)Kaposiform hemangioendothelioma further broadens the phenotype of PIK3CA-related overgrowth spectrum Clin Genet. 100 624-50
[7]  
Lindhurst MJ(2021)Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation Am J Hum Genet. 108 942-70
[8]  
Parker VER(2018)Cancer-Associated PIK3CA Mutations in Overgrowth Disorders Trends Mol Med. 24 856-33
[9]  
Payne F(2014)Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum Am J Med Genet Part A 164 1713-24
[10]  
Sapp JC(2017)Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel J Mol Diagn. 19 613-97